Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese HSK 1 – For Medical Students & Physicians A complete 20-lesson, 300-page Chinese HSK 1 course with a companion app in 21 languages — free forever. Arabic, Bengali, Dutch, English, Farsi, French, German, Hindi, Indonesian, Italian, Japanese, Korean, Portuguese, Russian, Spanish, Tagalog, Thai, Turkish, Ukrainian, Urdu, Vietnamese. By Bernd Sebastian Kamps and Andrea Melis

Diabetes

Free Subscription 23.03.2026 1 Am J Cardiol 3 Am J Clin Nutr 1 Am J Med 2 Am J Ophthalmol 1 Ann Intern Med 2 Biochem Biophys Res Commun 1 BMC Ophthalmol 1 BMC Pediatr 11 Diabet Med 6 Diabetes 13 Diabetes Care 21 Diabetes Obes Metab 5 Diabetologia 2 J Am Soc Nephrol 2 J Clin Endocrinol Metab 1 J Clin Invest 3 J Diabetes Complications 1 J Nutr 1 Kidney Int 1 Lancet 2 Metabolism 2 Nutr Metab (Lond) 1 Obstet Gynecol 10 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Cardiol

1. MORTADA I, Lee A, Quach V, Rice J, et al
   Early Tirzepatide Use After Acute Myocardial Infarction or Ischemic Stroke in Patients Without Diabetes: A Real-World Propensity-Matched Study.
   Am J Cardiol. 2026 Mar 18:S0002-9149(26)00162.
   PubMed         Abstract available
   
   

   
   Am J Clin Nutr

2. CHEN F, Mangano KM, Scott TM, Li W, et al
   Diabetes modifies the association between magnesium and insomnia, but not depressive symptomatology, in Puerto Rican adults: A prospective cohort study.
   Am J Clin Nutr. 2026 Mar 18:101285. doi: 10.1016/j.ajcnut.2026.101285.
   PubMed         Abstract available
   
   
3. REN J, Sun X, Zhang Z, Zhang Y, et al
   Baseline body mass index modifies the effects of digital health interventions versus usual care on cardiovascular risk in people with type 2 diabetes: a secondary analysis of the SMARTDiabetes trial.
   Am J Clin Nutr. 2026 Mar 18:101282. doi: 10.1016/j.ajcnut.2026.101282.
   PubMed         Abstract available
   
   
4. ARCOT A, Gallagher K, Goldstein JA, Gernand AD, et al
   The relationship between maternal glucose concentrations, gestational diabetes mellitus, and adverse fetal growth and gestational age outcomes: a retrospective cohort study.
   Am J Clin Nutr. 2026 Mar 16:101280. doi: 10.1016/j.ajcnut.2026.101280.
   PubMed         Abstract available
   
   

   
   Am J Med

5. JOSHI D
   Ophthalmic safety considerations when initiating GLP-1 receptor agonists in patients with diabetic retinopathy.
   Am J Med. 2026;139:e122.
   PubMed        
   
   

   
   Am J Ophthalmol

6. LIN BH, Chuang SH, Wu LC, Chen YP, et al
   Association of Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists with Risk of Cataract.
   Am J Ophthalmol. 2025 Dec 26:S0002-9394(25)00687.
   PubMed         Abstract available
   
   
7. GARG I, Duich M, Uwakwe C, Wai KM, et al
   Swept-Source OCT Angiography Vascular Metrics as Biomarkers for Renal Function in Patients with Diabetes Mellitus.
   Am J Ophthalmol. 2026 Mar 17:S0002-9394(26)00136.
   PubMed         Abstract available
   
   

   
   Ann Intern Med

8. KANAYA AM, Gadgil MD
   In adults with prediabetes and overweight or obesity, an AI- vs. human-led lifestyle intervention was noninferior for a composite outcome at 12 mo.
   Ann Intern Med. 2026;179:JC34.
   PubMed         Abstract available
   
   

   
   Biochem Biophys Res Commun

9. BAO F, Wang J, Jin L, Zhang L, et al
   Myoglobin in disease: the good and the bad.
   Biochem Biophys Res Commun. 2026;809:153502.
   PubMed         Abstract available
   
   
10. MOHAMMAD AL SHAHRANI M, Abohassan M, Dera AA, Vijayaraghavalu S, et al
    Integrated discovery of SBLR876: a potent RAGE inhibitor mitigating AGE-RAGE-NF-kappaB-mediated cytotoxicity and inflammation in diabetic kidney disease.
    Biochem Biophys Res Commun. 2026;811:153540.
    PubMed         Abstract available
    
    

    
    BMC Ophthalmol

11. LIN M, Zhang G, Wu H, Xiong Y, et al
    Two-stage diagnostic intervals in diabetic retinopathy and associated factors: a cross-sectional study.
    BMC Ophthalmol. 2026;26:143.
    PubMed         Abstract available
    
    

    
    BMC Pediatr

12. OLGA K, Mareike N, Erika M, Thekla VDB, et al
    Protection through early knowledge: clinical onset of type 1 diabetes in children and adolescents with and without early T1D detection programmes.
    BMC Pediatr. 2026 Mar 21. doi: 10.1186/s12887-026-06737.
    PubMed        
    
    

    
    Diabet Med

13. NADERPOUR S, Gillies C, O'Riordan P, Fahimfar N, et al
    Association between type 2 diabetes and site-specific fracture risk: A systematic review and meta-analysis of cohort studies including over 13 million participants.
    Diabet Med. 2026 Mar 13:e70276. doi: 10.1111/dme.70276.
    PubMed         Abstract available
    
    
14. WHITE SL, Schoenaker D, Mackin S, Forde R, et al
    A call to action: A consensus statement on knowledge gaps and research priorities on the management of women with early onset type 2 diabetes in the preconception, pregnancy and postnatal periods: A report from the Diabetic Medicine Symposium at the D
    Diabet Med. 2026 Mar 13:e70252. doi: 10.1111/dme.70252.
    PubMed         Abstract available
    
    
15. MEI K, Casabar M, Mukuba D, Byrne C, et al
    Efficacy of glucagon-like peptide-1 receptor analogues in kidney transplant recipients with diabetes: A single-centre retrospective study.
    Diabet Med. 2026 Mar 15:e70248. doi: 10.1111/dme.70248.
    PubMed        
    
    
16. STEPHENS JW, Dhatariya K, Beamish AJ, Pournaras DJ, et al
    Diabetes management in people undergoing metabolic-bariatric surgery: A guideline from the Joint British Diabetes Societies for Inpatient Care (JBDS-IP) Group.
    Diabet Med. 2026 Mar 16:e70281. doi: 10.1111/dme.70281.
    PubMed         Abstract available
    
    
17. LEE AH, Stokes G, Farrell K, Holmes-Walker DJ, et al
    Improving glycaemic outcomes with subsidised access to diabetes technology in a young adult population with type 1 diabetes.
    Diabet Med. 2026 Mar 17:e70261. doi: 10.1111/dme.70261.
    PubMed         Abstract available
    
    
18. BIBBY BM, Bach E, Christensen M, Fisker S, et al
    Sampling duration matters: Intraindividual variation of glycaemic metrics in type 1 diabetes using automated insulin delivery.
    Diabet Med. 2026 Mar 19:e70272. doi: 10.1111/dme.70272.
    PubMed         Abstract available
    
    
19. ZHOU J, Li S, Lv L, Luo G, et al
    LncRNA VCAN-AS1 serves as a diagnostic biomarker and drives pathogenesis in diabetic nephropathy via the miR-205-5p/VEGFA axis.
    Diabet Med. 2026 Mar 19:e70259. doi: 10.1111/dme.70259.
    PubMed         Abstract available
    
    
20. JORDAN JE, Litterbach E, Geerling R, Lam EP, et al
    Meaningful engagement of lived experience in diabetes research and health service improvement: A rapid review of barriers to and enablers for community involvement among adults with type 2 diabetes.
    Diabet Med. 2026 Mar 20:e70274. doi: 10.1111/dme.70274.
    PubMed         Abstract available
    
    
21. DAPRE E, Barrett E, McMillan B, Pilkington A, et al
    Testing the feasibility of an intermittent low-energy diet in women with gestational diabetes.
    Diabet Med. 2026 Mar 20:e70258. doi: 10.1111/dme.70258.
    PubMed         Abstract available
    
    
22. GUI W, Cao H, Chai J
    Methodological considerations in psychosocial research on advanced diabetic retinopathy: Towards inclusive assessment of cognitively impaired patients.
    Diabet Med. 2026 Mar 20:e70221. doi: 10.1111/dme.70221.
    PubMed        
    
    
23. HABTE-ASRES HH, Nartey C, Afuwape S
    Beyond vision: The emotional toll of advanced diabetic retinopathy response to the letter.
    Diabet Med. 2026 Mar 20:e70296. doi: 10.1111/dme.70296.
    PubMed        
    
    

    
    Diabetes

24. DELGADO-CORRALES B, Fingerhut L, Leung P, Yau CSA, et al
    Distinct Enterovirus Antigen Landscape in Children With Islet Autoimmunity.
    Diabetes. 2026 Feb 9:db250805. doi: 10.2337/db25-0805.
    PubMed         Abstract available
    
    
25. LIN S, Lytle KA, Fink N, Jensen MD, et al
    Adipose Tissue Resistance to the Antilipolytic Effect of Insulin and Niacin in Humans With Obesity.
    Diabetes. 2026 Feb 17:db250979. doi: 10.2337/db25-0979.
    PubMed         Abstract available
    
    
26. DWYER JR, Racine JJ, Chapman HD, Bell A, et al
    Multiple Mechanisms Contribute to Robust Type 1 Diabetes Protection in Nfkbid- Overexpressing NOD Mice.
    Diabetes. 2026 Mar 20:db250956. doi: 10.2337/db25-0956.
    PubMed        
    
    
27. MONTASER E, Sosenko JM, Ismail HM
    Predicting the Timing of the Metabolic Inflection Point in Type 1 Diabetes Progression Using Machine Learning and Survival Analysis Models.
    Diabetes. 2026 Mar 20:db250961. doi: 10.2337/db25-0961.
    PubMed         Abstract available
    
    
28. PAGE B
    Diabetes Spotlight: Dawn Belt Davis, MD, PhD-Strengthening beta-Cell Functionality by Identifying Signaling Pathways.
    Diabetes. 2026;75:593-594.
    PubMed        
    
    
29. PUGLIESE A
    Distinct Host Responses to Enterovirus in Children With Islet Autoimmunity Provide a New Framework for the Role of Infections in Type 1 Diabetes.
    Diabetes. 2026;75:603-605.
    PubMed        
    
    

    
    Diabetes Care

30. MARZINOTTO I, Pittman DL, Achenbach P, Akolkar B, et al
    Interlaboratory Evaluation of Multiplex Autoantibody Assay Performance in the Islet Autoantibody Standardization Program 2024 Workshop.
    Diabetes Care. 2026;49:607-615.
    PubMed         Abstract available
    
    
31. RETNAKARAN R, Shen J, Hanley AJ, Zinman B, et al
    Impact of an Additional Pregnancy on the Natural History of Insulin Sensitivity, beta-Cell Function, and Glycemia in Parous Women.
    Diabetes Care. 2026;49:664-673.
    PubMed         Abstract available
    
    
32. HUANG X, Tian Z, Pan Y, Zhang J, et al
    A U-Shaped Association Between Blood mtDNA Copy Number and Risk of Type 2 Diabetes.
    Diabetes Care. 2026 Mar 16:dc252198. doi: 10.2337/dc25-2198.
    PubMed         Abstract available
    
    
33. JANG S, Wang Y, Ma S, Hsia DS, et al
    Improving the Algorithm: The Inclusion of a Socioeconomic Status Measure in Predicting Type 2 Diabetes Development in Youth With Prediabetes.
    Diabetes Care. 2026 Mar 16:dc253060. doi: 10.2337/dc25-3060.
    PubMed         Abstract available
    
    
34. WEISKORN J, Becker M, Kamrath C, Hammersen J, et al
    Hypercholesterolemia and Lipid-Lowering Therapy in Children and Adolescents With Type 1 Diabetes: Do We Implement Current Guidelines?
    Diabetes Care. 2026 Mar 17:dc252459. doi: 10.2337/dc25-2459.
    PubMed         Abstract available
    
    
35. HARJUTSALO V, Thorn LM, Sandholm N, Groop PH, et al
    Shrunken Pore Syndrome and Risk of Cardiovascular Disease and All-Cause Mortality in Individuals With Type 1 Diabetes With and Without Albuminuria.
    Diabetes Care. 2026 Mar 17:dc252987. doi: 10.2337/dc25-2987.
    PubMed         Abstract available
    
    
36. ZHU Y, Ngo AL, Liao LD, Harvill R, et al
    Data-Driven Phenotypic Clusters of Gestational Diabetes Mellitus and Associations With Risk of Perinatal Complications and Postpartum Diabetes.
    Diabetes Care. 2026 Mar 17:dc252131. doi: 10.2337/dc25-2131.
    PubMed         Abstract available
    
    
37. PARK CM, Thanapluetiwong S, Chen X, Oh G, et al
    Response to Comment on Park et al. Sodium-Glucose Cotransporter 2 Inhibitors, Glucagon-Like Peptide 1 Receptor Agonists, and Frailty Progression in Older Adults With Type 2 Diabetes. Diabetes Care 2026;49:147-151.
    Diabetes Care. 2026;49:e75-e76.
    PubMed        
    
    
38. CHAN JCN
    Redefining Diabetes and Creating Solutions-The Hong Kong Diabetes Register: Kelly West Award Lecture 2025.
    Diabetes Care. 2026;49:544-558.
    PubMed         Abstract available
    
    
39. MALTESE G, Sinclair AJ
    Comment on Park et al. Sodium-Glucose Cotransporter 2 Inhibitors, Glucagon-Like Peptide 1 Receptor Agonists, and Frailty Progression in Older Adults With Type 2 Diabetes. Diabetes Care 2026;49:147-151.
    Diabetes Care. 2026;49:e73-e74.
    PubMed        
    
    
40. HERMAN WH
    Comment on Pop-Busui et al. Screening Natriuretic Peptide Levels Predicts Heart Failure and Death in Individuals With Type 1 and Type 2 Diabetes Without Known Heart Failure. Diabetes Care 48:2145-2153.
    Diabetes Care. 2026;49:e77-e78.
    PubMed        
    
    
41. PAULL ME
    Seventeen Alarms at 3 a.m.: Environmental Trauma During Hospital Care for Diabetic Ketoacidosis.
    Diabetes Care. 2026;49:540-541.
    PubMed        
    
    
42. MANCO M, Gastaldelli A
    Rethinking Liver Transaminases to Predict Diabetes Risk in Children With MASLD.
    Diabetes Care. 2026;49:578-580.
    PubMed        
    
    

    
    Diabetes Obes Metab

43. PONNANA SR, Zhang T, Sirasapalli SK, Chen Z, et al
    Risk stratification using coronary artery calcium and potential benefit of semaglutide therapy: A cost-effectiveness modelling study.
    Diabetes Obes Metab. 2026;28:3229-3237.
    PubMed         Abstract available
    
    
44. CHONG MY, Henson J, Bours MJL, Bosma H, et al
    Physical activity and meal timing alignment with chronotype and their associations with glucose metabolism: The Maastricht Study.
    Diabetes Obes Metab. 2026;28:3295-3304.
    PubMed         Abstract available
    
    
45. WELTERS A, Reinauer C, Schwab KO, Boettcher C, et al
    Highly Uncontrolled Cardiovascular Risk in Emerging Adults With Paediatric-Onset Type 1 Diabetes-A Cross-Sectional Analysis From the Diabetes Prospective Follow-Up Registry DPV.
    Diabetes Obes Metab. 2026 Mar 16. doi: 10.1111/dom.70610.
    PubMed         Abstract available
    
    
46. LIU W, Xing R, Cai X, Zhu Y, et al
    A Four-Variant T1D Genetic Risk Score to Classify Type 1 and Monogenic Diabetes in Chinese Patients.
    Diabetes Obes Metab. 2026 Mar 19. doi: 10.1111/dom.70664.
    PubMed        
    
    
47. HUANG Z, Wu Y, Tang C, Yao B, et al
    A Multicentre, Randomised, Controlled, Open-Label Study of Continuous Subcutaneous Insulin Infusion Plus Henagliflozin for Treating Type 2 Diabetes Mellitus Patients With Severe Hyperglycaemia.
    Diabetes Obes Metab. 2026 Mar 19. doi: 10.1111/dom.70665.
    PubMed         Abstract available
    
    
48. JUN JE, Kim S, Jeong IK, Kim JH, et al
    Dementia Risk in Type 1 and 2 Diabetes: A Nationwide Population-Based Comparison.
    Diabetes Obes Metab. 2026 Mar 19. doi: 10.1111/dom.70677.
    PubMed         Abstract available
    
    
49. BIANCHI C, Del Prato S, Rothberg AE, Nauck MA, et al
    Challenging the Consensus Statement: Is It Time to Recognise Pharmacological Remission of Type 2 Diabetes?
    Diabetes Obes Metab. 2026 Mar 19. doi: 10.1111/dom.70674.
    PubMed         Abstract available
    
    
50. WU Y, Pang J, Xu S, Leelarathna L, et al
    Artificial Intelligence in Type 1 Diabetes Management: A Scoping Review of Randomised Controlled Trials.
    Diabetes Obes Metab. 2026 Mar 19. doi: 10.1111/dom.70671.
    PubMed         Abstract available
    
    
51. WEI L, Haghpanahan H, Wild SH, Geue C, et al
    A Type 2 Diabetes Policy Model That Predicts Remaining Life Expectancy, Quality-Adjusted Life Expectancy and Healthcare Costs for Use in Economic Evaluation, Incorporating Equity Concerns.
    Diabetes Obes Metab. 2026 Mar 19. doi: 10.1111/dom.70657.
    PubMed         Abstract available
    
    
52. CLAVERO-JIMENO A, Martin-Olmedo JJ, Migueles JH, Camacho-Cardenosa A, et al
    Sleep Efficiency Predicts Next-Day Glycaemia and Daytime Glycaemia Influences Sleep in Free-Living Adults at Risk of Type 2 Diabetes.
    Diabetes Obes Metab. 2026 Mar 19. doi: 10.1111/dom.70675.
    PubMed         Abstract available
    
    
53. CHANG R, Redman LM, Ravussin E, Apovian CM, et al
    Effect of Caloric Restriction on Predicted Risk of Incident Cardiovascular Disease and Type 2 Diabetes in Young Adults: Findings From the CALERIE 2 Trial.
    Diabetes Obes Metab. 2026 Mar 19. doi: 10.1111/dom.70684.
    PubMed        
    
    
54. RANDAZZO R, Cannarella R, Condorelli RA, Calogero AE, et al
    Early Real-World Implementation of Once-Weekly Insulin Icodec in Type 2 Diabetes.
    Diabetes Obes Metab. 2026 Mar 18. doi: 10.1111/dom.70652.
    PubMed        
    
    
55. SUN M, Zang D, Chen J
    HbA1c
    Diabetes Obes Metab. 2026 Mar 16. doi: 10.1111/dom.70670.
    PubMed        
    
    
56. WU Y, Fu H, Zhu M, Yao Y, et al
    Dapansutrile preserves pancreatic beta-cell function by regulating insulin vesicle membrane fusion and mitochondrial homeostasis.
    Diabetes Obes Metab. 2026;28:3054-3069.
    PubMed         Abstract available
    
    
57. PEMBERTON JS, Andrews RC, Barnard-Kelly K, Battelino T, et al
    International clinical opinion on transparency, standardisation, and calibration alignment in the performance evaluation of systems for continuous glucose monitoring.
    Diabetes Obes Metab. 2026;28:2551-2565.
    PubMed         Abstract available
    
    
58. SCHILLER T, Gabay L, Barak O, Kirzhner A, et al
    An oral glucose tolerance test in pregnancy and its association with future cardiovascular diseases.
    Diabetes Obes Metab. 2026;28:3146-3154.
    PubMed         Abstract available
    
    
59. KITAO S, Okura T, Ito Y, Endo S, et al
    Methylglyoxal-derived hydroimidazolone (MG-H1) is a novel marker of insulin resistance in Japanese individuals, disturbing insulin signalling via mTORC2 in cultured myocytes.
    Diabetes Obes Metab. 2026;28:3020-3032.
    PubMed         Abstract available
    
    
60. HASEBE M, Su CY, Kamido H, Yabe D, et al
    GLP-1 receptor agonists and cardiovascular outcomes in Asian, Black or African American, and White populations: An updated meta-analysis including the SOUL trial.
    Diabetes Obes Metab. 2026;28:2806-2814.
    PubMed         Abstract available
    
    
61. SARKER J, Okpara E, De Los Santos B, Kim M, et al
    Comparative effectiveness of GLP-1 receptor agonists, SGLT2 inhibitors and DPP-4 inhibitors on liver outcomes in metabolic dysfunction-associated steatotic liver disease: A retrospective cohort study.
    Diabetes Obes Metab. 2026;28:3155-3164.
    PubMed         Abstract available
    
    
62. AMANI-BENI R, Darouei B, Mortaheb M, Haghighatpanah MA, et al
    Associations between anthropometric measures of obesity and prediabetes risk: A dose-response meta-analysis of cohort studies.
    Diabetes Obes Metab. 2026;28:2536-2550.
    PubMed         Abstract available
    
    
63. MIGLIOZZI L, Fadini GP
    Targeting gut-derived NETosis: A paradigm shift in understanding metformin's therapeutic action.
    Diabetes Obes Metab. 2026;28:2511-2522.
    PubMed         Abstract available
    
    

    
    Diabetologia

64. MCCLURE RD, Carr ALJ, Boule NG, Yardley JE, et al
    The glycaemic response to morning fasted resistance exercise is more consistent than the response to afternoon fed resistance exercise for adults with type 1 diabetes: a randomised crossover comparison.
    Diabetologia. 2026 Mar 14. doi: 10.1007/s00125-026-06713.
    PubMed         Abstract available
    
    
65. DU Y, Zhang M, Li AQY, Lau ESH, et al
    Differential healthcare costs in individuals with type 2 diabetes and incident chronic kidney disease in Hong Kong: a latent class trajectory analysis.
    Diabetologia. 2026 Mar 18. doi: 10.1007/s00125-026-06698.
    PubMed         Abstract available
    
    
66. PENG R, Liu L, Chu X, Xia Z, et al
    Plasma metabolite association profiles for type 2 diabetes genetic clusters in Finnish men.
    Diabetologia. 2026 Mar 18. doi: 10.1007/s00125-026-06710.
    PubMed         Abstract available
    
    
67. ZHU D, Ma J, Wang W, Shi B, et al
    Correction: Efficacy and safety of efsubaglutide alfa in individuals with type 2 diabetes (SUPER1): a randomised, double-blind, placebo-controlled, Phase IIb/III trial.
    Diabetologia. 2026 Mar 19. doi: 10.1007/s00125-026-06711.
    PubMed        
    
    
68. MOLLER PM, Kjobsted R, Petersen MH, de Almeida ME, et al
    Correction: Effect of acute exercise and exercise training on the ability of insulin to clear branched?chain amino acids from plasma in obesity and type 2 diabetes.
    Diabetologia. 2026 Mar 19. doi: 10.1007/s00125-026-06690.
    PubMed        
    
    

    
    J Am Soc Nephrol

69. LEVIN-IAINA N, Reiner-Benaim A, Abu-Akel S, Habashi N, et al
    Authors' Reply: Gestational Diabetes as a Window into Underdocumented CKD in Women.
    J Am Soc Nephrol. 2026 Mar 19. doi: 10.1681/ASN.0000001064.
    PubMed        
    
    
70. DONG J, Shi S
    Gestational Diabetes as a Window into Underdocumented CKD in Women.
    J Am Soc Nephrol. 2026 Mar 19. doi: 10.1681/ASN.0000001063.
    PubMed        
    
    

    
    J Clin Endocrinol Metab

71. ATILA C, Refardt J, Christ-Crain M
    Arginine Vasopressin Deficiency and Oxytocin Deficiency in the Endocrine Clinic.
    J Clin Endocrinol Metab. 2026;111:922-937.
    PubMed         Abstract available
    
    
72. JAO J, Mukonda E, Madlala HP, Myer L, et al
    Gestational diabetes in South African women with HIV and HIV-seronegative women: Results from the ORCHID cohort.
    J Clin Endocrinol Metab. 2026 Mar 17:dgag111. doi: 10.1210.
    PubMed         Abstract available
    
    

    
    J Clin Invest

73. SHI H, Yao H, Liu Y, Fan M, et al
    BM-derived mesenchymal stem cell microvesicles protect enteric neural precursor cells and alleviate diabetes-associated enteric neuropathy.
    J Clin Invest. 2026;136:e192437.
    PubMed         Abstract available
    
    

    
    J Diabetes Complications

74. DA SILVA AMP, Januario Campos Cardoso L, Batista S, Goncalves OR, et al
    Tirzepatide versus semaglutide for the prevention of mild cognitive impairment, dementia, and Alzheimer's disease in type 2 diabetes: A real-world, retrospective cohort study.
    J Diabetes Complications. 2026;40:109306.
    PubMed         Abstract available
    
    
75. KEISALA E, Kauppala T, Vanhamaki S, Haapakoski J, et al
    Potential years of life lost and factors associated with different causes of death in type 1 diabetes in Finland.
    J Diabetes Complications. 2026;40:109312.
    PubMed         Abstract available
    
    
76. IWAMOTO T, Hidaka S, Iwamoto M, Shibata H, et al
    Pre-treatment estimated glomerular filtration rate trajectory modifies the renoprotective effect of finerenone in patients with chronic kidney disease associated with type 2 diabetes.
    J Diabetes Complications. 2026;40:109308.
    PubMed         Abstract available
    
    

    
    J Nutr

77. MOHAMMADI H, Ghoflchi S, Abass KS, Hosseini H, et al
    Synergistic Therapeutic Potential of Curcumin and Metformin: a Multipathway Approach to Disease Management.
    J Nutr. 2026;156:101362.
    PubMed         Abstract available
    
    

    
    Kidney Int

78. WAN F, Yang B, Li J, Lin L, et al
    Proteinase 3 Drives Murine Diabetic Kidney Disease by Mediating Caspase-3-dependent Apoptosis of Podocytes.
    Kidney Int. 2026 Mar 13:S0085-2538(26)00163-8. doi: 10.1016/j.kint.2026.
    PubMed         Abstract available
    
    

    
    Lancet

79. KASUJJA FX, Aikaeli F, Garrib A, van Widenfelt E, et al
    Integrated community-based versus facility-based care for people with HIV, diabetes, and hypertension in sub-Saharan Africa (INTE-COMM): an open-label, multicountry, cluster-randomised trial.
    Lancet. 2026;407:1084-1094.
    PubMed         Abstract available
    
    

    
    Metabolism

80. CHEN L, Dong X, Zhang Q, Wang H, et al
    Once-weekly insulin GZR4 versus once-daily insulin degludec in Chinese people with type 2 diabetes: A multicenter, open-label, randomized, phase 2 trial.
    Metabolism. 2026;179:156592.
    PubMed         Abstract available
    
    
81. KHADIVI Y, Tavallaeinejad P, Hashemipour M, Khachikian A, et al
    Mapping circulating microRNA signatures in type 1 diabetic microvascular disease: A systematic review and Bayesian multilevel meta-analysis with bioinformatic integration of molecular dysregulation.
    Metabolism. 2026 Mar 13:156591. doi: 10.1016/j.metabol.2026.156591.
    PubMed         Abstract available
    
    

    
    Nutr Metab (Lond)

82. WANG F, Li X, Gao X, Liang J, et al
    Metabolomics reveals early pregnancy serum metabolic changes and predictive biomarkers in gestational diabetes mellitus.
    Nutr Metab (Lond). 2026 Mar 14. doi: 10.1186/s12986-026-01107.
    PubMed         Abstract available
    
    
83. WU L, Fan G, Zhang L, Bi J, et al
    Previous oral glucose tolerance test results as predictors of gestational diabetes mellitus in subsequent pregnancies: a retrospective cohort study.
    Nutr Metab (Lond). 2026 Mar 17. doi: 10.1186/s12986-026-01109.
    PubMed        
    
    

    
    Obstet Gynecol

84. FIELD C, Grobman WA, Mast D, Wu J, et al
    Diabetes Testing Immediately Postpartum After Gestational Diabetes Mellitus: A Randomized Controlled Trial.
    Obstet Gynecol. 2026 Mar 12. doi: 10.1097/AOG.0000000000006236.
    PubMed         Abstract available
    
    

    
    PLoS One

85. XIONG W, Li Y, Huang J, He G, et al
    Cancer risk associated with DPP4 inhibitors in type 2 diabetes: A pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS).
    PLoS One. 2026;21:e0345281.
    PubMed         Abstract available
    
    
86. AMANTE D, Malkani S, Haas R, Wang B, et al
    Effectiveness of a pharmacist diabetes coaching program: A propensity-matched retrospective analysis.
    PLoS One. 2026;21:e0345534.
    PubMed         Abstract available
    
    
87. YANG J, Xu D, Liu X, Zhao Z, et al
    The triglyceride-glucose index and neutrophil-to-lymphocyte ratio jointly predict the no-reflow phenomenon in T2DM patients with STEMI after primary PCI.
    PLoS One. 2026;21:e0345466.
    PubMed         Abstract available
    
    
88. YAHYA H, Draman N, Kadir AA, Yaacob NM, et al
    Features of mobile apps for diabetic kidney disease self-management: A scoping review.
    PLoS One. 2026;21:e0331604.
    PubMed         Abstract available
    
    
89. SAEED A, Jiang M, Ali Yasin N, Zhao J, et al
    From medicine price control to deregulation: assessing policy effects on insulin access in Pakistan's private pharmacies.
    PLoS One. 2026;21:e0337151.
    PubMed         Abstract available
    
    
90. LIU J, Li D, Huang J, Hu Y, et al
    CD99-targeted immunomagnetic negative selection: A novel strategy for high-purity pancreatic islet isolation in murine models.
    PLoS One. 2026;21:e0344446.
    PubMed         Abstract available
    
    
91. LIU L, Jacobson B, Stefanovic D
    PID-controller enhanced artificial beta-cells.
    PLoS One. 2026;21:e0342799.
    PubMed         Abstract available
    
    
92. TECHATANAWAT S, Surarit R, Chairatvit K, Khovidhunkit W, et al
    Correction: Salivary and serum interleukin-17A and interleukin-18 levels in patients with type 2 diabetes mellitus with and without periodontitis.
    PLoS One. 2026;21:e0345302.
    PubMed         Abstract available
    
    
93. MAALOUF M, Tammam M, Kurungadan S, Alsereidi A, et al
    An inflammatory biomarker panel for prediabetes classification using interpretable machine learning.
    PLoS One. 2026;21:e0341195.
    PubMed         Abstract available
    
    
94. CHEN Y, Duan Y, Zhang J, Cai T, et al
    Effects of music therapy in patients with diabetic retinopathy undergoing pan?retinal photocoagulation.
    PLoS One. 2026;21:e0344435.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Diabetes is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum